Diebold Nixdorf, Incorporated (DBD) Key Metrics
DBD valuation today
Trailing 12 months · as of October 18, 2026- Market cap
- $2.27B
- Enterprise value
- $2.80B
- P/E (TTM)
- 22.1
- Forward P/E
- 12.2
- PEG ratio
- —
- Price / sales
- 0.6 10-yr median 0.5
- Price / book
- 2.2 10-yr median 1.8
- EV / EBITDA
- 7.4 10-yr median 9.3
- Dividend yield
- —
- Beta
- 1.19
DBD key metrics, 2016–2025
Fiscal year ended December 31, 2025 · U.S. dollarsDBD valuation Price multiples at each fiscal year-end price.
DBD returns How much profit the business earns on the capital it uses.
DBD per-share figures Results divided by the shares outstanding at year-end.
DBD financial health Debt, liquidity and how easily interest is covered.
DBD efficiency & capital use Working capital cycle and where the cash goes.
DBD valuation history
DBD returns on capital
Net income (ROE, ROA) or after-tax operating income (ROIC) divided by the average of the opening and closing balance.
DBD debt vs cash
Debt includes short- and long-term borrowings and, where reported, lease liabilities.
DBD cash returned to shareholders
DBD price vs earnings per share
DBD key metrics
2016–2025| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Valuation | ||||||||||
| Market capitalization | $2.53B | $1.62B | $1.86B | — | — | — | — | — | — | — |
| Enterprise value | $3.28B | $2.35B | $2.66B | — | — | — | — | — | — | — |
| P/E ratio | 26.7 | — | 1.4 | — | — | — | — | — | — | — |
| Price / sales | 0.7 | 0.4 | 0.5 | — | — | — | — | — | — | — |
| Price / book | 2.3 | 1.7 | 1.8 | — | — | — | — | — | — | — |
| Price / free cash flow | 9.6 | 12.3 | — | — | — | — | — | — | — | — |
| Price / operating cash flow | 8.4 | 10.8 | — | — | — | — | — | — | — | — |
| EV / sales | 0.9 | 0.6 | 0.7 | — | — | — | — | — | — | — |
| EV / EBITDA | 9.8 | 7.0 | 9.3 | — | — | — | — | — | — | — |
| EV / free cash flow | 12.5 | 17.8 | — | — | — | — | — | — | — | — |
| Earnings yield | 3.7% | −1.0% | 73.9% | — | — | — | — | — | — | — |
| Free cash flow yield | 10.4% | 8.1% | −15.1% | — | — | — | — | — | — | — |
| Shareholder yield (dividends + buybacks) | 5.2% | 0.0% | — | — | — | — | — | — | — | — |
| Share price at fiscal year-end | $67.89 | $43.04 | $28.95 | — | — | — | — | — | — | — |
| Per share | ||||||||||
| Revenue per share | $102.30 | $99.76 | $58.43 | $43.81 | $49.87 | $50.29 | $57.47 | $60.24 | $61.05 | $47.99 |
| Earnings per share | $2.54 | −$0.44 | $21.38 | −$7.36 | −$1.01 | −$3.47 | −$4.45 | −$7.48 | −$3.20 | −$2.58 |
| Operating cash flow per share | $8.08 | $3.97 | −$3.99 | −$4.91 | $1.57 | $0.23 | $1.77 | −$1.37 | $0.49 | $0.41 |
| Free cash flow per share | $7.08 | $3.51 | −$4.38 | −$5.58 | $0.92 | −$0.34 | $1.21 | −$2.14 | −$0.87 | −$0.57 |
| Cash per share | $11.19 | $8.33 | $8.76 | $4.20 | $5.40 | $4.66 | $3.79 | $5.09 | $8.27 | $10.37 |
| Book value per share | $29.57 | $24.73 | $16.53 | −$17.48 | −$10.79 | −$10.66 | −$6.91 | −$2.45 | $5.90 | $8.56 |
| Tangible book value per share | −$9.00 | −$11.57 | −$6.83 | −$29.63 | −$24.73 | −$26.75 | −$23.42 | −$21.55 | −$19.14 | −$17.07 |
| Dividends per share | — | — | — | — | — | $0.00 | $0.00 | $0.10 | $0.41 | $0.93 |
| Capex per share | $1.01 | $0.46 | $0.39 | $0.67 | $0.66 | $0.58 | $0.56 | $0.77 | $1.36 | $0.98 |
| Debt per share | $31.56 | $27.85 | $21.09 | $34.50 | $31.29 | $32.15 | $30.12 | $29.47 | $24.55 | $26.02 |
| Shares outstanding | 37.2M | 37.6M | 64.4M | 79.0M | 78.3M | 77.6M | 76.7M | 76.0M | 75.5M | 69.1M |
| Change in shares outstanding | −1.1% | −41.6% | −18.5% | +0.9% | +0.9% | +1.2% | +0.9% | +0.7% | +9.3% | +5.3% |
| Returns & profitability | ||||||||||
| Return on equity (ROE) | 9.3% | −1.7% | — | — | — | — | — | — | −46.6% | −35.5% |
| Return on invested capital (ROIC) | 15.2% | 5.2% | 5.7% | −15.2% | 8.7% | 1.4% | 11.8% | −17.2% | 6.4% | 4.0% |
| Return on assets (ROA) | 2.6% | −0.4% | 38.1% | −17.7% | −2.2% | −7.2% | −8.4% | −11.9% | −4.6% | −4.7% |
| Return on tangible assets | 3.9% | −0.8% | 51.8% | −27.6% | −3.3% | −11.2% | −13.5% | −19.9% | −7.2% | −5.1% |
| Free cash flow margin | 6.9% | 3.5% | −7.5% | −12.7% | 1.8% | −0.7% | 2.1% | −3.6% | −1.4% | −1.2% |
| Income quality (OCF / net income) | 3.18 | — | −0.19 | — | — | — | — | — | — | — |
| Financial health | ||||||||||
| Total debt | $1.17B | $1.05B | $1.36B | $2.73B | $2.45B | $2.50B | $2.31B | $2.24B | $1.85B | $1.80B |
| Cash & short-term investments | $416.4M | $313.1M | $563.6M | $332.0M | $423.2M | $361.7M | $290.9M | $386.6M | $624.6M | $716.8M |
| Net debt | $757.7M | $734.0M | $793.8M | $2.39B | $2.03B | $2.13B | $2.02B | $1.85B | $1.23B | $1.08B |
| Debt / equity | 1.07 | 1.13 | 1.28 | — | — | — | — | — | 4.16 | 3.04 |
| Debt / assets | 0.30 | 0.30 | 0.33 | 0.89 | 0.70 | 0.68 | 0.61 | 0.52 | 0.35 | 0.34 |
| Net debt / EBITDA | 2.26 | 2.19 | 2.79 | — | 6.90 | 12.01 | 10.45 | — | 6.92 | — |
| Current ratio | 1.30 | 1.32 | 1.52 | 1.10 | 1.08 | 1.13 | 1.18 | 1.40 | 1.38 | 1.44 |
| Quick ratio | 0.92 | 0.90 | 1.10 | 0.74 | 0.77 | 0.82 | 0.89 | 1.02 | 0.98 | 1.03 |
| Interest coverage | 3.9 | 1.2 | 0.4 | -1.1 | 0.7 | 0.1 | 1.2 | -2.3 | 1.2 | 0.6 |
| Working capital | $415.3M | $401.6M | $732.9M | $166.0M | $137.9M | $207.8M | $292.4M | $635.0M | $684.5M | $795.1M |
| Invested capital | $1.86B | $1.66B | $1.86B | $1.01B | $1.18B | $1.31B | $1.49B | $1.67B | $1.67B | $1.67B |
| Tangible asset value | −$330.0M | −$426.8M | −$424.4M | −$2.33B | −$1.93B | −$2.06B | −$1.75B | −$1.48B | −$916.5M | −$702.3M |
| Net current asset value | −$962.8M | −$937.4M | −$928.9M | −$2.67B | −$2.46B | −$2.61B | −$2.38B | −$2.14B | −$1.77B | −$1.58B |
| Graham number | $41.13 | — | $89.17 | — | — | — | — | — | — | — |
| Graham net-net per share | −$43.43 | −$42.20 | −$26.15 | −$42.42 | −$40.90 | −$43.48 | −$42.86 | −$40.74 | −$35.03 | −$35.09 |
| Capital allocation | ||||||||||
| Dividends paid | — | — | — | — | — | $0 | $0 | $7.7M | $30.6M | $64.6M |
| Share buybacks (net) | $130.7M | $0 | — | — | — | — | $1.9M | $3.0M | $5.0M | $2.2M |
| Dividends + buybacks / free cash flow | 49.6% | 0.0% | — | — | — | — | 2.0% | — | — | — |
| Capex / revenue | 1.0% | 0.5% | 0.7% | 1.5% | 1.3% | 1.1% | 1.0% | 1.3% | 2.2% | 2.0% |
| Capex / operating cash flow | 12.4% | 11.7% | — | — | 41.6% | 248.3% | 31.6% | — | 276.3% | 238.4% |
| Capex / depreciation | 0.29 | 0.13 | 0.18 | 0.42 | 0.34 | 0.25 | 0.19 | 0.23 | 0.41 | 0.50 |
| Stock-based compensation / revenue | 0.3% | 0.3% | 0.4% | 0.4% | 0.4% | 0.4% | 0.5% | 0.8% | 0.7% | 0.7% |
| R&D / revenue | 2.2% | 2.5% | 2.9% | 3.5% | 3.2% | 3.4% | 3.3% | 3.4% | 3.4% | 3.2% |
| SG&A / revenue | 16.6% | 17.2% | — | 21.4% | 19.9% | 22.0% | 20.6% | — | — | — |
| Efficiency | ||||||||||
| Days sales outstanding | 57.4 | 63.7 | 64.7 | 63.7 | 58.0 | 59.2 | 56.2 | 62.4 | 69.2 | 74.5 |
| Days of inventory on hand | 68.3 | 72.1 | 74.5 | 76.4 | 66.5 | 61.4 | 59.0 | 65.6 | 74.0 | 78.6 |
| Days payables outstanding | 58.0 | 63.8 | 72.2 | 89.0 | 76.9 | 61.8 | 53.7 | 53.0 | 57.2 | 59.8 |
| Cash conversion cycle (days) | 67.7 | 72.0 | 67.1 | 51.1 | 47.6 | 58.8 | 61.4 | 74.9 | 86.0 | 93.3 |
| Receivables turnover | 6.35 | 5.73 | 5.64 | 5.73 | 6.29 | 6.16 | 6.50 | 5.85 | 5.27 | 4.90 |
| Payables turnover | 6.29 | 5.72 | 5.06 | 4.10 | 4.75 | 5.90 | 6.79 | 6.88 | 6.38 | 6.10 |
| Inventory turnover | 5.34 | 5.07 | 4.90 | 4.78 | 5.49 | 5.94 | 6.19 | 5.57 | 4.93 | 4.64 |
| Asset turnover | 1.03 | 0.97 | 1.04 | 1.05 | 1.09 | 1.05 | 1.09 | 0.96 | 0.88 | 0.88 |
| Average receivables | $599.0M | $655.1M | $667.0M | $603.7M | $621.0M | $633.1M | $678.2M | $782.5M | $874.5M | $676.5M |
| Average payables | $445.6M | $494.6M | $570.3M | $659.0M | $603.1M | $485.7M | $490.5M | $535.9M | $561.4M | $421.1M |
| Average inventory | $524.5M | $559.0M | $589.0M | $566.1M | $521.2M | $482.4M | $538.3M | $662.3M | $726.1M | $553.5M |
| Intangibles / total assets | 37.2% | 38.5% | 36.1% | 31.3% | 31.1% | 34.1% | 33.4% | 33.7% | 36.2% | 33.6% |
Computed from DBD's annual financial statements (latest annual report filed February 12, 2026) and the closing share price on each fiscal year-end, adjusted for stock splits. Figures in U.S. dollars; data from EODHD. Averages use the opening and closing balance of each year.
DBD valuation and financial ratios
At the end of fiscal 2025 (December 31, 2025), Diebold Nixdorf traded at 26.7 times earnings. Based on the latest twelve months, the trailing P/E is 22.1 and the forward P/E is 12.2. Diebold Nixdorf earned a return on equity of 9.3% and a return on invested capital of 15.2% in fiscal 2025. It ended the year with $1.2 billion of debt and $416.4 million in cash and short-term investments, net debt of $757.7 million. It returned $130.7 million to shareholders: $0 in dividends and $130.7 million in share buybacks, 50% of free cash flow. The share count fell 46.2% from 69.1M to 37.2M over 9 years.
See the DBD income statement, the DBD chart for price history, or the DBD stock overview for the latest quote and news.
DBD key metrics FAQ
What is Diebold Nixdorf's P/E ratio?
Diebold Nixdorf's trailing P/E ratio is 22.1 based on the last twelve months of earnings (as of October 18, 2026), and its forward P/E is 12.2. At the end of fiscal 2025 it was 26.7.
What is Diebold Nixdorf's EV/EBITDA?
Diebold Nixdorf's enterprise value was 9.8 times EBITDA at the end of fiscal 2025 (enterprise value $3.3 billion, EBITDA $334.8 million); the current EV/EBITDA is 7.4.
What is Diebold Nixdorf's return on equity?
Diebold Nixdorf's return on equity (ROE) was 9.3% in fiscal 2025: net income of $94.6 million on average shareholders' equity of $1.0 billion.
What is Diebold Nixdorf's ROIC?
Diebold Nixdorf's return on invested capital was 15.2% in fiscal 2025, using after-tax operating income divided by average debt plus equity minus cash.
How much debt does Diebold Nixdorf have?
Diebold Nixdorf had total debt of $1.2 billion at the end of fiscal 2025, a debt-to-equity ratio of 1.07 and $757.7 million of net debt (2.26 times EBITDA).
Does Diebold Nixdorf buy back its shares?
Yes. Diebold Nixdorf spent $130.7 million on net share repurchases in fiscal 2025 Shares outstanding changed −1.1% over the year, to 37.2M..
What is Diebold Nixdorf's free cash flow yield?
Diebold Nixdorf generated $263.3 million of free cash flow in fiscal 2025, a free cash flow yield of 10.4% on its market value at year-end ($2.5 billion).
What is Diebold Nixdorf's current ratio?
Diebold Nixdorf's current ratio was 1.30 at the end of fiscal 2025: current assets were 1.30 times current liabilities.